The problem is this is kind of a catch-22 for drug companies.  If they only release a new antibiotic in IV form, meaning it will only be administered at hospitals, they don&#x27;t get enough volume to make money.  So why research the next one?<p>In general I&#x27;m a pretty free-market guy, but this is one area I&#x27;d like to see the government more involved, both in subsidizing new antibiotic development and in making sure we have a stock of antibiotics that still work.